Heart Test Laboratories (HSCSW) EBITDA

Annual EBITDA

-$6.16 M
-$180.33 K-3.02%

April 30, 2024


Summary


Performance

HSCSW EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherHSCSWprofitabilitymetrics:

Quarterly EBITDA

-$1.93 M
+$64.94 K+3.25%

October 31, 2024


Summary


Performance

HSCSW Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherHSCSWprofitabilitymetrics:

TTM EBITDA

-$7.20 M
-$375.50 K-5.50%

October 31, 2024


Summary


Performance

HSCSW TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherHSCSWprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

HSCSW EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.0%0.0%0.0%
3 y3 years-142.6%0.0%0.0%
5 y5 years-64.8%0.0%0.0%

HSCSW EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-142.6%at low-76.7%+3.3%-152.0%at low
5 y5-year-142.6%at low-362.8%+3.3%-823.0%at low
alltimeall time-142.6%at low-362.8%+3.3%-823.0%at low

Heart Test Laboratories EBITDA History

DateAnnualQuarterlyTTM
Oct 2024
-
-$1.93 M(-3.3%)
-$7.20 M(+5.5%)
Jul 2024
-
-$2.00 M(+14.1%)
-$6.83 M(+41.3%)
Apr 2024
-$6.16 M(+3.0%)
-$1.75 M(+14.6%)
-$4.83 M(+56.8%)
Jan 2024
-
-$1.53 M(-1.9%)
-$3.08 M(+7.8%)
Oct 2023
-
-$1.56 M(+19.4%)
-$2.86 M(-55.8%)
Apr 2023
-$5.98 M
-
-
Jan 2023
-
-$1.30 M(-26.3%)
-$6.46 M(+3.4%)
DateAnnualQuarterlyTTM
Oct 2022
-
-$1.77 M(+24.1%)
-$6.25 M(+15.0%)
Jul 2022
-
-$1.42 M(-27.7%)
-$5.44 M(+22.7%)
Apr 2022
-$4.68 M(+84.4%)
-$1.97 M(+80.2%)
-$4.43 M(+36.7%)
Jan 2022
-
-$1.09 M(+15.0%)
-$3.24 M(+50.9%)
Oct 2021
-
-$950.25 K(+127.7%)
-$2.15 M(+79.4%)
Jul 2021
-
-$417.27 K(-46.5%)
-$1.20 M(+53.5%)
Apr 2021
-$2.54 M(-32.0%)
-$780.21 K
-$780.21 K
Apr 2020
-$3.73 M
-
-

FAQ

  • What is Heart Test Laboratories annual EBITDA?
  • What is the all time high annual EBITDA for Heart Test Laboratories?
  • What is Heart Test Laboratories annual EBITDA year-on-year change?
  • What is Heart Test Laboratories quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Heart Test Laboratories?
  • What is Heart Test Laboratories quarterly EBITDA year-on-year change?
  • What is Heart Test Laboratories TTM EBITDA?
  • What is the all time high TTM EBITDA for Heart Test Laboratories?
  • What is Heart Test Laboratories TTM EBITDA year-on-year change?

What is Heart Test Laboratories annual EBITDA?

The current annual EBITDA of HSCSW is -$6.16 M

What is the all time high annual EBITDA for Heart Test Laboratories?

Heart Test Laboratories all-time high annual EBITDA is -$2.54 M

What is Heart Test Laboratories annual EBITDA year-on-year change?

Over the past year, HSCSW annual EBITDA has changed by -$180.33 K (-3.02%)

What is Heart Test Laboratories quarterly EBITDA?

The current quarterly EBITDA of HSCSW is -$1.93 M

What is the all time high quarterly EBITDA for Heart Test Laboratories?

Heart Test Laboratories all-time high quarterly EBITDA is -$417.27 K

What is Heart Test Laboratories quarterly EBITDA year-on-year change?

Over the past year, HSCSW quarterly EBITDA has changed by $0.00 (0.00%)

What is Heart Test Laboratories TTM EBITDA?

The current TTM EBITDA of HSCSW is -$7.20 M

What is the all time high TTM EBITDA for Heart Test Laboratories?

Heart Test Laboratories all-time high TTM EBITDA is -$780.21 K

What is Heart Test Laboratories TTM EBITDA year-on-year change?

Over the past year, HSCSW TTM EBITDA has changed by $0.00 (0.00%)